Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pearl River Delta Sets Up Biopharm R&D Supply Chain Alliance

This article was originally published in PharmAsia News

Executive Summary

Guangzhou Biological Engineering Center, together with more than 60 biopharmaceutical enterprises and academic institutions in Pearl River Delta, recently formed a biopharmaceutical R&D supply chain alliance. The grouping aims to gain more purchasing clout by establishing a mutually beneficial relationship with local and overseas suppliers through integrated supply chain resources to increase efficiency and convenience. The alliance will set up a biopharmaceutical online portal for R&D materials purchase and develop it into an advanced e-business platform that spurs local innovation. GBEC has approached many R&D teams as purchasers and disclosed that more than 150 suppliers of international biopharmaceutical devices, consumables and reagents have indicated their interest in joining the alliance. (Click here for more - Chinese Language)
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC071653

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel